Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,693 | 1,031 | 96.6% |
| Education | $583.78 | 27 | 3.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.1% |
| Consulting Fee | $20.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,722 | 173 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,397 | 129 | $0 (2024) |
| Amgen Inc. | $1,547 | 69 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,522 | 123 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $1,114 | 64 | $0 (2023) |
| ABBVIE INC. | $1,084 | 53 | $0 (2024) |
| Lilly USA, LLC | $1,030 | 67 | $0 (2024) |
| GlaxoSmithKline, LLC. | $761.08 | 37 | $0 (2024) |
| PFIZER INC. | $703.54 | 39 | $0 (2024) |
| Astellas Pharma US Inc | $628.41 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,485 | 115 | Amgen Inc. ($561.84) |
| 2023 | $1,984 | 106 | Novo Nordisk Inc ($313.55) |
| 2022 | $2,204 | 126 | Amgen Inc. ($261.28) |
| 2021 | $2,048 | 112 | AbbVie Inc. ($392.40) |
| 2020 | $2,359 | 143 | Novo Nordisk Inc ($432.51) |
| 2019 | $2,244 | 141 | AstraZeneca Pharmaceuticals LP ($409.67) |
| 2018 | $2,315 | 146 | Novo Nordisk Inc ($508.22) |
| 2017 | $2,682 | 171 | AstraZeneca Pharmaceuticals LP ($465.93) |
All Payment Transactions
1,060 individual payment records from CMS Open Payments — Page 1 of 43
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Cardio-renal | ||||||
| 12/14/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: Insulin Pump | ||||||
| 12/13/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.68 | General |
| Category: Insulin Pump | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.50 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.22 | General |
| Category: DIABETES | ||||||
| 12/10/2024 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: VACCINES | ||||||
| 12/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $35.78 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/27/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Bone Health | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.98 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Cardiology | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/20/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 11/13/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $28.36 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $4.53 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: PAIN | ||||||
| 11/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: Biological | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $25.74 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.49 | General |
| Category: Inflammation | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 779 | 1,306 | $201,990 | $97,360 |
| 2022 | 17 | 904 | 1,498 | $231,835 | $132,047 |
| 2021 | 17 | 1,000 | 1,687 | $275,795 | $137,988 |
| 2020 | 16 | 843 | 1,237 | $186,965 | $85,591 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 43 | 354 | $35,400 | $21,144 | 59.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 167 | $37,575 | $18,978 | 50.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 126 | 126 | $31,500 | $18,388 | 58.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 178 | $35,600 | $14,243 | 40.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 55 | 56 | $16,800 | $4,021 | 23.9% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 31 | 31 | $12,400 | $3,983 | 32.1% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2023 | 27 | 42 | $6,300 | $3,373 | 53.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 124 | 124 | $6,200 | $2,657 | 42.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 35 | 35 | $4,375 | $2,352 | 53.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 63 | 64 | $3,200 | $2,185 | 68.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $3,250 | $2,011 | 61.9% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 33 | 52 | $2,600 | $1,472 | 56.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 31 | 31 | $3,100 | $1,432 | 46.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 15 | 22 | $3,300 | $945.52 | 28.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $390.00 | $175.11 | 44.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 52 | 387 | $38,700 | $27,715 | 71.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 91 | 164 | $36,900 | $23,326 | 63.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 111 | 219 | $43,800 | $22,166 | 50.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 131 | 131 | $32,750 | $19,411 | 59.3% |
| 99491 | Chronic care management services for two or more chronic conditions, first 30 minutes provided personally by health care professional, per calendar month | Office | 2022 | 40 | 96 | $14,400 | $9,284 | 64.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 82 | 82 | $10,250 | $7,434 | 72.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 73 | 74 | $22,200 | $5,062 | 22.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 18 | $7,200 | $4,968 | 69.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 88 | 90 | $4,455 | $3,061 | 68.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $3,575 | $2,467 | 69.0% |
About Dr. Shabnam Sachdeva, M.D
Dr. Shabnam Sachdeva, M.D is a Family Medicine healthcare provider based in Fairfax, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598786717.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shabnam Sachdeva, M.D has received a total of $18,322 in payments from pharmaceutical and medical device companies, with $2,485 received in 2024. These payments were reported across 1,060 transactions from 59 companies. The most common payment nature is "Food and Beverage" ($17,693).
As a Medicare-enrolled provider, Sachdeva has provided services to 3,526 Medicare beneficiaries, totaling 5,728 services with total Medicare billing of $452,986. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Fairfax, VA
- Active Since 07/22/2006
- Last Updated 10/18/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598786717
Products in Payments
- FARXIGA (Drug) $1,494
- JARDIANCE (Drug) $1,241
- Ozempic (Drug) $1,230
- Otezla (Drug) $539.69
- Victoza (Drug) $529.26
- Repatha (Biological) $454.18
- TRULICITY (Drug) $433.06
- Vascepa (Drug) $400.28
- TOUJEO (Drug) $367.88
- XIFAXAN (Drug) $367.78
- EVENITY (Biological) $364.75
- SYNTHROID (Drug) $341.85
- BREZTRI (Drug) $339.62
- TRELEGY ELLIPTA (Drug) $339.13
- UBRELVY (Drug) $320.34
- QULIPTA (Drug) $304.88
- MOUNJARO (Drug) $291.32
- INVOKANA (Drug) $278.24
- Wegovy (Drug) $269.39
- SOLIQUA (Drug) $268.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fairfax
Dr. Kavian Milani, M.d, M.D
Family Medicine — Payments: $15,958
Michael Kim, Md, MD
Family Medicine — Payments: $10,193
Dr. Jasmine Moghissi, M.d, M.D
Family Medicine — Payments: $9,595
Mrs. Starla Allen, D.o, D.O
Family Medicine — Payments: $6,467
Carrington Koebele, M.d, M.D
Family Medicine — Payments: $5,638
Dr. Francis O'connor, Md, MD
Family Medicine — Payments: $2,756